Arxspan Now Servicing SAFE-BioPharma Community

Arxspan, the developer of the web-based ArxLab electronic laboratory notebook (ELN), has joined with SAFE-BioPharma Association to provide services that can facilitate research collaboration within the community of biopharmaceutical companies comprising SAFE-BioPharma’s members.

“Browser-based digital ELN signatures significantly reduce the barriers to signature compliance for external research initiatives,” said Peter Rosati, CEO of Arxspan.

SAFE-BioPharma is the not-for-profit biopharmaceutical industry coalition managing the global SAFE-BioPharma digital identity and signature standard. High assurance digital identity credentials based on the SAFE-BioPharma standard are used in the biopharmaceutical and healthcare sectors to sign electronic documents and data files, and to authenticate to online applications.

ArxLab, a full-featured and browser-based ELN built for collaborative research, now incorporates digital signing certificates compliant with the SAFE-BioPharma standard, allowing personnel with SAFE-BioPharma cyber-identities to authenticate identity and apply digital signatures when using the ArxLab ELN.

“We are pleased to welcome Arxspan to the expanding community of SAFE-BioPharma organizations,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association.

SAFE-BioPharma

For more information on the SAFE-BioPharma standard for digital identity and digital signatures used in life science and healthcare settings, visit https://www.safe-biopharma.org.

ARXSPAN/ARXLAB

For more information on Arxspan and the ArxLab suite of products for the life science, food science, and chemical industries, visit https://www.arxspan.com.

< | >